Structural Heart Occluders

This channel includes news and new technology innovations about structural heart occluders. These include information of surgical repair and transcatheter closure of PFO, VSD, ASD and LAA. Devices include the Amplatzer and the Gore Helex

Feature | August 25, 2011

August 25, 2011 – Transcatheter structural heart occluder maker Occlutech said this week it closed a 15 million Euro...

News | June 29, 2011

June 29, 2011 – For the first time, human blood vessels grown in a laboratory from donor skin cells have been...

News | May 16, 2011

May 16, 2011 - The German Supreme Court (BGH) declared a structural heart occluder patent case to be invalid. In the...

News | May 10, 2011

Alcohol Injections Safer, Less Costly Than Surgery for Thickened Heart Muscle

May 10, 2011 – In a “real-world...

News | March 07, 2011

March 4, 2011 - Occlutech GmbH received a favorable court ruling in Stockholm, Sweden in the ongoing patent...

News | November 15, 2010

November 15, 2010 - A catheter procedure that closes a hole in patients’ hearts appears to be no more...

News | November 03, 2010

November 3, 2010 – The first patient has been enrolled into a study comparing a left atrial appendage (LAA) closure...

News | October 29, 2010

The first-in-man use of the Coherex WaveCrest left atrial appendage (LAA) occluder system was successfully...

News | October 25, 2010

October 25, 2010 – The Hague, Netherlands ruled in favor of Occlutech, a transcatheter structural heart...

Feature | October 18, 2010

St. Jude Medical Inc. said it plans to acquire AGA Medical Holdings Inc. for about $1.3 billion. The purchase will...

News | October 04, 2010

October 4, 2010 – Germany will reimburse patients who have a left atrial appendage closure procedure in...

News | September 28, 2010

September 28, 2010 – The Transcatheter Cardiovascular Therapeutics (TCT) 2010 symposium featured a live...

News | September 22, 2010

September 23, 2010 – The first consensus document for treating structural heart disease has been published by the...

The Watchman device is a transcatheter left atrial appendage occluder. It is meant to be an alternative to blood thinners in preventing stroke in patients with atrial fibrillation.

Feature | September 07, 2010 | John Kao, M.D., FACC and Anupama Shivaraju, M.D.

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and is a major risk factor for developing...

The Gore Helex septal occluder.

News | August 25, 2010

August 25, 2010 – Alleging infringement of a patent for its transcatheter cardiac septal occluder devices,...

Overlay Init